Delay in OnabotulinumtoxinA Treatment During the COVID‐19 Pandemic‐Perspectives from a Virus Hotspot
Ashhar Ali
Abstract
The COVID-19 pandemic has undoubtedly changed our practice of medicine. With our collective resources and attention focused on caring for those afflicted with the disease, other medical conditions have temporarily but understandably faced constraint. For migraine patients who often require in-person visits for infusions and procedures, this has become particularly challenging. Here, we share our experience in navigating this exigency amidst a local surge of COVID-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineIntensive care medicineVirologyDiseaseInfectious disease (medical specialty)Internal medicineOutbreakMigraine and Headache StudiesSympathectomy and Hyperhidrosis TreatmentsBotulinum Toxin and Related Neurological Disorders